1 / 19

How to follow-up patients

Why do we follow-up patients who have had germ cell tumors?. To detect relapse: in the belief that earlier detection improves chance of cure To detect contralateral testis tumors To manage late toxicity For reassurance, support and counselling To collect data. First indication of relapse in TE

ely
Télécharger la présentation

How to follow-up patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. How to follow-up patients Professor Gordon Rustin Director of Medical Oncology Mount Vernon Cancer Centre Northwood UK

    2. Why do we follow-up patients who have had germ cell tumors?

    3. First indication of relapse in TE08 stage I surveillance trial

    4. Characteristics of relapse following therapy for germ cell tumour

    5. Relapses > 2 years after completion of therapy for germ cell tumours

    6. Localization of late relapses Oldenburg, Martin & Fossa J Clin Oncol 24: 5503-11, 2006

    7. Adapting frequency of follow-up investigations to risk of relapse

    8. ESMO Minimum Clinical Recommendations for Follow-up of NSGCT stage 1 on surveillance

    9. ESMO Minimum Clinical Recommendations for Follow-up of NSGCT after chemotherapy

    10. Royal Marsden Minimum Clinical Recommendations for Follow-up for stage 1 seminoma on surveillance

    11. ESMO Minimum Clinical Recommendations for Follow-up for stage 1 seminoma after adjuvant therapy

    12. ESMO Minimum Clinical Recommendations for Follow-up of seminoma after metastatic disease

    13. Risks of excess CT scans

    14. Definitions of Metabolic Syndrome

    15. Investigations to be performed at 2, 5 and 10 years to detect late effects of therapy for germ cell tumors

    16. Questions related to follow-up of patients with germ cell

    17. LDH should not be measured routinely in follow-up of germ cell tumours

    18. Malignant teratoma 32 years after treatment of germ cell tumor confined to testis. Pavic M, Meeus P, Treilleux I, Droz JP. Urology. 2006 Apr;67(4):846

    19. How should we organise our follow-up to detect the rare very late relapse?

More Related